Pure Global
NCT06119178

EX-PRESS® P-50 and EX-PRESS® P-200

Alcon Research·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Glaucoma
Drug/Device/Intervention
EX-PRESS P-50 filtration device
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Alcon Research
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2023
End date
Jul 01, 2024
Enrollment
100 participants
Primary outcome

Percentage reduction in intraocular pressure (IOP) from baseline

Summary

The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term
 clinical performance and safety outcomes for EX-PRESS Glaucoma Filtration Devices Models P-50
 and P-200.

ICD-10 classifications
GlaucomaGlaucomaOther glaucomaGlaucoma, unspecifiedGlaucoma in diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06119178
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06119178 through Pure Global AI's free database. This phase not specified trial is sponsored by Alcon Research and is currently Not yet recruiting. The study focuses on Glaucoma. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.